Award Year / Program / Phase:2010 / SBIR / Phase I
Agency:HHS
Principal Investigator:Dorre Grueneberg – (713) 798-8167
Award Amount:$203,208.00
Abstract:
The Augusta founding laboratories have used cutting edge genetic technologies and shRNA screening methodologies to uncover the ROS receptor tyrosine kinase as a cancer survival gene. Studies from other laboratories have drawn a clear link between ROS kinase activity and the development and/or… More